Mereo BioPharma Group plc (MREO) stock
MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.29+0.01 (+5.39%)
Close on Nov 18, 2026Market cap $46.20MP/E –Yield –
Mereo BioPharma cash
Cash and short-term investments held at the end of each period.
Mereo BioPharma's cash was $26.10M at Sep 30, 2026. For fiscal 2025 it was $40.99M, down 41.3% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.99M | -41.3% |
| FY2024 | Dec 31, 2024 | $69.80M | +21.6% |
| FY2023 | Dec 31, 2023 | $57.42M | -15.8% |
| FY2022 | Dec 31, 2022 | $68.18M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $26.10M | -46.4% |
| Q2 FY2026 | Jun 30, 2026 | $30.12M | -46.3% |
| Q1 FY2026 | Mar 31, 2026 | $30.10M | -51.8% |
| Q4 FY2025 | Dec 31, 2025 | $40.99M | -41.3% |
| Q3 FY2025 | Sep 30, 2025 | $48.70M | -39.5% |
| Q2 FY2025 | Jun 30, 2025 | $56.13M | -35.8% |
| Q1 FY2025 | Mar 31, 2025 | $62.48M | +28.4% |
| Q4 FY2024 | Dec 31, 2024 | $69.80M | +21.6% |
| Q3 FY2024 | Sep 30, 2024 | $80.52M | +18.1% |
| Q2 FY2024 | Jun 30, 2024 | $87.43M | – |
| Q1 FY2024 | Mar 31, 2024 | $48.66M | – |
| Q4 FY2023 | Dec 31, 2023 | $57.42M | – |
| Q4 FY2022 | Dec 31, 2022 | $68.18M | – |
See a number that looks wrong?